Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 41: 367-374, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spencer, C. A.
Right arrow Articles by Wilkinson, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spencer, C. A.
Right arrow Articles by Wilkinson, E.

Clinical Chemistry, Vol 41, 367-374, Copyright © 1995 by American Association for Clinical Chemistry

Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH

CA Spencer, M Takeuchi, M Kazarosyan, F MacKenzie, GJ Beckett and E Wilkinson
University of Southern California, Department of Medicine, Los Angeles 90033.

Clinically relevant interassay precision profiles for thyrotropin (thyroid-stimulating hormone; TSH) were constructed with human serum pools measured over 4-8 weeks by six immunometric assays, in at least two different reagent lots. Functional sensitivities (the concentration at which the interassay CV is < or = 20%) were determined in four to eight clinical laboratories plus the respective manufacturer's laboratory. These studies revealed that the manufacturer's stated functional sensitivity limit is rarely duplicated in clinical practice. Loss of specificity (indicated by artifactually high values) was seen with some methods when used to measure certain unrefrigerated low-TSH sera. Measurement of TSH in four human serum pools (TSH < 0.05-0.25 mIU/L) by 16 different methods (each in at least eight UK or US laboratories) showed that some methods could not reliably distinguish subnormal from normal TSH values. Better pool rankings and fewer misclassifications of low-TSH sera as "normal" were seen with use of assays capable of "third-generation" functional sensitivity (0.01-0.02 mIU/L) than with assays with "second-generation" functional sensitivity (0.1-0.2 mIU/L). Because inter- and intramethod differences in functional sensitivity negatively impact the diagnostic accuracy and cost-effectiveness of a TSH-centered thyroid-testing strategy, laboratories should independently establish an assay's functional sensitivity by a clinically relevant protocol. Moreover, manufacturers should assess functional sensitivity more realistically and improve the robustness of assays to ensure that their performance potential is consistently met in clinical practice.


The following articles in journals at HighWire Press have cited this article:


Home page
Eur J EndocrinolHome page
M. Boas, J. L. Forman, A. Juul, U. Feldt-Rasmussen, N. E. Skakkebaek, L. Hilsted, M. Chellakooty, T. Larsen, J. F. Larsen, J. H Petersen, et al.
Narrow intra-individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women
Eur. J. Endocrinol., December 1, 2009; 161(6): 903 - 910.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. Biondi and D. S. Cooper
The Clinical Significance of Subclinical Thyroid Dysfunction
Endocr. Rev., February 1, 2008; 29(1): 76 - 131.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Zophel, G. Wunderlich, and J. Kotzerke
Should We Really Determine a Reference Population for the Definition of Thyroid-Stimulating Hormone Reference Interval?
Clin. Chem., February 1, 2006; 52(2): 329 - 330.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Donadio, A. Pascual, J. H.H. Thijssen, and C. Ronin
Feasibility Study of New Calibrators for Thyroid-Stimulating Hormone (TSH) Immunoprocedures Based on Remodeling of Recombinant TSH to Mimic Glycoforms Circulating in Patients with Thyroid Disorders
Clin. Chem., February 1, 2006; 52(2): 286 - 297.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
T. M. Li, T. Chuang, S. Tse, D. Hovanec-Burns, and A. S. El Shami
Development and Validation of a Third Generation Allergen-Specific IgE Assay on the Continuous Random Access IMMULITE(R) 2000 Analyzer
Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 67 - 74.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Uettwiller-Geiger, A. H.B. Wu, F. S. Apple, A. W. Jevans, P. Venge, M. D. Olson, C. Darte, D. L. Woodrum, S. Roberts, and S. Chan
Multicenter Evaluation of an Automated Assay for Troponin I
Clin. Chem., June 1, 2002; 48(6): 869 - 876.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Becker, T. Piironen, J. Kiviniemi, H. Lilja, and K. Pettersson
Sensitive and Specific Immunodetection of Human Glandular Kallikrein 2 in Serum
Clin. Chem., February 1, 2000; 46(2): 198 - 206.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. A. Sadler, M. H. Smith, L. M. Murray, and J. G. Turner
A pragmatic approach to estimating total analytical error of immunoassays
Clin. Chem., April 1, 1997; 43(4): 608 - 614.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. McIver, P. Rae, G. Beckett, E. Wilkinson, A. Gold, and A. Toft
Lack of Effect of Thyroxine in Patients with Graves' Hyperthyroidism Who Are Treated with an Antithyroid Drug
N. Engl. J. Med., January 25, 1996; 334(4): 220 - 224.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.